Cl2A-SN-38

CAS : 1279680-68-0

Ref. 3D-EBC68068

Informations sur le produit

• Nom: Cl2A-SN-38

Description

Cl2A-SN-38 is a novel anticancer drug that has demonstrated significant antitumor activity in preclinical animal models of lymphocytic leukemia. Cl2A-SN-38 is a bioconjugate composed of the chemotherapeutic agent SN-38 and the monoclonal antibody Cl2A. The Cl2A binds to tumor cells and targets them for destruction by the SN-38, which is released from the conjugate and enters into the cell through receptor mediated endocytosis. The drug has been shown to have synergistic effects when combined with radiation or other chemotherapy drugs. It has also been shown to induce apoptotic signaling in tumor cells, leading to cell death without affecting normal tissue.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,480.6 g/mol
• Formule: C₇₃H₉₇N₁₁O₂₂
• Degré de pureté: Min. 95%